17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/
Related
A 360-degree view of compliance is an effort to incorporate your compliance identity into a holistic...
Read More >
Financial institutions M&A sector trends: stock exchanges/clearing houses/trading venues — H2 2019 ...
Read More >
In DLO Enterprises, Inc. v. Innovative Chemical Products Group, LLC, the Delaware Court of Chancery ...
Read More >
As a plan sponsor being investigated by an Internal Revenue Service (IRS) agent, there is one thing ...
Read More >
The National Labor Relations Board (NLRB) recently issued another decision benefitting employers by ...
Read More >
A trial court in New York has ruled that a title insurance policy excluded coverage of claims agains...
Read More >